Articles related to DELUSIONS/HALLUCINATIONS
Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits
Explore the recent meta-analysis that delves into the potential of cholinesterase inhibitors in treating delusions and hallucinations in dementia patients. The findings reveal significant but clinically insignificant effects, highlighting the need for further research and targeted treatments.
Psychiatry August 15th 2023
Illicit Neurology: Taking Issue When the Other Illicit Shoe Drops
This brief editorial introduces a series of articles describing the medical use of hallucinogens, ketamine, marijuana, and other agents — including the legal and ethical perspectives — in the treatment of various neurologic and psychiatric disorders.
Neurology December 6th 2022
Case 34-2022: A 57-Year-Old Woman with COVID-19 and Delusions
In this case report, two Massachusetts psychiatrists, together with a radiologist and gerontologist, walk through the diagnosis and management of new onset neuropsychiatric symptoms following COVID infection.
Neurology November 29th 2022